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Plants of the genus Scutellana constitute one of the most common components of Eastern and traditional American medicines against various human ailments, including cancer. Extracts and isolated active components from Scutellaria have antiinflammatory [1] , (2] , antioxidative [1] , [21, [3] , anxiolytic [ 4 1. [5] , and antiviral [2] activity. Among its various species, Scutel!aria baicalensis is the most widely studied [6] , 1 7 1, [8] , [9] , [10] , followed by S.barbata [II] , 1121, [13] . A recent study illustrated the antiproliferative effect of S. baicalensis root extract in drug-resistant gliomas when used alone and in conjunction with the alkylating drug, carmustine (BCNU) [7] . Scutellaria extract comprises one of the eight constituents of the herbal mixture PC-SPES, which is widely used by prostate cancer patients as a supplementary treatment [14] . A phase I clinical trial has recently been concluded using BZLIOI, an aqueous extract from S. barbata, in patients with advanced breast cancer (15] . Studies affecting primary or non-malignant cells. The fiavonoids exhibited different mechanisms of antitumor activity as well as positive interactions. The antitumor mechanisms involved induction of apoptosis and cell cycle arrest at G1/G2. Of the extracts tested, leaf extracts of S. angulosa, S. integrifolia, S. ocmulgee and S. scandens were found to have strong anticancer activity. This study provides basis for further mechanistic and translational studies into adjuvant therapy of malignant tumors using Scutellana leaf tissues.
Supporting information available online at http://www.thieme-connect.de/ejournals/toc/ plantamedica on Scutellaria have most commonly utilized the roots. Although aerial parts are also known to be substantially rich in phytochemicals of medicinal value, antitumor activities of leaf and stem extracts have not been explored. Flavonoids constitute a major phytochemical component of Scute!laria extracts. The two most common, baicalein and baicalin, have shown antiproliferative and proapoptotic activities against various cancer cells [16] , [17] , [18] , [19] . Baicalein has also shown a favorable effect in cisplatin-induced cell death of human glioma cells [19] . There are few reports on the anticancer activity of apigenin [20] , [21] , [221 and wogonin [13] , [23] , whereas the antitumor properties of other Scutellaria flavonoids, including chrysin and scutellarein, have rarely been studied. Paucity of knowledge on the phytochemical composition and mechanisms of antitumor activity of Scutellaria triggered our study, to further explore the therapeutic benefits of Scutellaria.
We report a comprehensive analysis of the anticancer activity of leaf, stem and root extracts ob-Origina tamed from thirteen different Scutellaria species using various human cell cultures, including gliomas, breast carcinoma, prostate carcinoma, normal primary human astrocyte, and non-malignant human mammary epithelial cell lines. The phytochemical composition of the extracts, with respect to the presence of six known flavonoids (apigenin, baicalein, baicalin, chrysin, scutellarein and wogonin), and their antineoplastic activity, either individually or in combination, are also reported.
Materials and Methods
V Cell lines and flavonoids
Human malignant glioma cell lines U87-MG and U251; malignant breast carcinoma MDA-MB-231, non-malignant human mammary epithelial cell (HMEC) and human prostate cancer cell line PC3 were purchased from the American Type Culture Collection and were cultured in DMEM/F12 supplemented with 10% fetal bovine serum (FBS). Normal human astrocytes (NHA) cultures were purchased from Lonza Inc. and maintained in their patented medium. Apigenin (purity 95%), baicalein (purity 98%), baicalin (purity 98%), chrysin (purity 96%) and genistein (purity 98%) were purchased from Sigma Chemical Co.; scutellarein (purity 96%) was from Indofine Chemical Co.; and wogonin (purity 98%) was purchased from Wako Chemicals. The flavonoids were dissolved in dimethyl sulfoxide to make a 20 m stock solution and diluted in DMEM/F12 before use.
Collection and cultivation of Scutellaria plants
Potted plants of S. montana and S. costaricana were obtained from Atlanta Botanical Garden (ABG) and were identified by Ron Gagliardo (ABG). S. ocmu!gee, S. ovata and S. integrifolia were identified and received from Tom Patrick, Botanist, Georgia Natural Heritage Program. Seeds of S. baicalensis, S. barbata and S. Iateriflora were purchased from Horizon Herbs, LLC. David Creech, Stephen F. Austin State University, identified and provided cuttings of S. suffrutescens. S. racemosa were collected at the FVSU campus. S. alpina was identified and provided by Dr. lkhlas A Khan, University of Mississippi. S.angulosa and S.scandens were procured as tissue cultured plantlets from Nepal Biotech Nursery, Kathmandu, Nepal. They were identified by Dr. Gopal S. Rawat (plant taxonomist) at the Wildlife Institute of India, Dehradun. All these specimens are preserved as herbaria and photographed at FVSU (contact N. Joshee). Herbarium sheets are arranged in alphabetical order as shown in 0 Table 1 (5 a!pina 001 to S suffrutescens 013). Tissue cultured plants were acclimatized in a mist chamber for one week and then transferred to soil at Specialty Plants House, Agricultural Research Station, FVSU. just before the onset of blooming, plants were uprooted with extreme care, washed gently to remove soil, and were blotted dry. Leaf, shoot, and root tissues were separated and the fresh weights recorded. The tissues were shade-dried at room temperature for 24 to 60 hours, depending on tissue type, until 70% moisture was lost, and then ground into powder.
Preparation of leaf, stem and root extracts
Extraction was performed using an ASE® apparatus (Dionex Corporation). Ten grams of dried samples were mixed with lOgof purified sand (Fisher Scientific) and loaded in extraction cartridges. Extraction was carried out using the following parameters: heat, 5mm; static, 10 mm; flush volume, 100 mL; purge, 90 sec; pressure, 1000 psi; temperature, 4°C; extraction solvent, Results are expressed as percent proliferation relative to the control, which was taken as 100% proliferation. Proliferation less than 60% is considered significant, and indicated in bold numbers. Data are means ± s. d. of three experiments.
methanol: water (80:20), four cycles. The extracts were concentrated under vacuum using a Savant SpeedVac (Savant Instruments, Inc). Aliquots of dried samples were weighed and used for analysis of flavorioids and for anticancer studies.
HPLC analysis of flavonoids
Dried extracts (10 mg) were dissolved in 450 pL of 0.1 % acetic acid in methanol and 50 pL of solution of 6-hydroxyflavone (internal standard, 600 pg/mL 0.1% acetic acid in methanol). Samples were analyzed by HPLC (Hewlett-Packard 1050) using an Inertsil ODS-2 5 a, 250 mm x 4.6 mm, column (MetaChem Technologies, Inc.), and monitored for their flavonoid content at A=270nm. The mobile phase was 0.005% phosphoric acid (A) and acetonitrile (B), eluted as follows: 30% B for 5 mm, ramped to 45% B from 5 min to 25 mm, ramped to 100% B from 25 min to 30 min and held for 3 mm. Solvent flow rate was I mL/min; volume of injection was 10 pL. Apigenin, baicalein, baicalin, chrysin, scutellarein and wogonin were quantitated from a calibration curve of commercial samples of the flavonoids.
Cell proliferation assay
Cells were seeded to 96-well flat-bottom plates (2 x 10 cells/ well), and cultured in the presence of Scutellaria extracts or flavonoids. After incubation at 37 °C for 4 days, cell viability was evaluated with the MIT assay, as described elsewhere 1241. The absorbance was measured at 570 nm in an Infinite-200 microplate reader (Tecan Systems Inc.). Cell viability was expressed as a percent of control (cells cultured with medium alone).
Apoptosis assay
U87-MG cells were plated (5 x ]05 cells/mL/well) in 12-well plates in the presence of Scutellaria extracts or flavonoids at indicated doses. After 72 or 96 h, cells were washed, stained with FITC-conjugated Annexin-V and propidium iodide (P1) (BD Pharmingen) and then analyzed in a flow cytometer (Becton-Dickinson FACScan), as previously described 1251. All cells that bound Annexin-V were considered apoptotic. Cells were also distributed into early apoptotic (bound with Annexin-V only) and late apoptotic/necrotic (bound with both Annexin-V and P1) cohorts. 
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Cell cycle analysis
U87-MG cells were plated (5 x iO cells/mL/well) in 12-well plates in medium without serum for 12 h in order to synchronize at the quiescent or GO phase of cell cycle. After 12 h, serum-free medium was replaced by medium containing 10% FBS.S cute flaria extracts and flavonoids were added at indicated doses.
After 72 h, cells were fixed and permeabilized with cold absolute ethanol for one hour. Following treatment with RNAse (100 pL at 100 mg/mL) for 15 minutes, cells were stained with P1 (50pg/ mL). DNA content was analyzed in a flow cytometer (FACScan; Becton-Dickinson). Data analysis was performed using the CellQuest and WinMDl software packages.
Statistical analysis
Wilcoxon's log-rank test was performed to determine statistical differences between various experimental and control groups using the SPSS package (SPSS Inc.) [26] . A p' value less than 0.05 was considered significant.
Results and Discussion
V
In the initial evaluation of the anticancer activity of the extracts at 500 pg/mL concentration using U87-MG, nine extracts showed inhibitory activity, measured as <60% cell proliferation compared to the control (100% proliferation). These extracts were: Table 1 ). At 250pg/mL concentration, only four leaf extracts (SanL, SinL SocL and SscL) showed significant anti-proliferative activity. The dose for 50% inhibition (IC50) of proliferation for these four extracts was approximately 500pg/mL(0 Table 1 ,0 Fig. 1 ).
HPLC analysis of the levels of apigenin, baicalein, baicalin, chrysin, scutellarein and wogonin in leaf, stem and root extracts showed various combinations of only three or four of the flavonoids in most extracts, except for SsuS and SsuR, which contained all six flavonoids (0 Table 2 and Supporting Information Table 52 ). The maximum concentration of a flavonoid detected in any extract was that of baicalein in SsuL (48.07 ± 4.12 Mg/mg extract) followed by S. baicalensis root (SbaR; 47.46 ± 0.10 pg/mg extract). The flavonoid concentrations were comparable to those reported in earlier studies [27] , [28] . Of the four extracts that showed significant anti-proliferative activity, all but SocL had detectable levels of baicalin and chrysin, combined with other flavonoids. On the other hand, SocL extract, which showed some of the best anti-proliferative activity, contained only wogonin. These results suggest that: 1) wogonin could potentially have very high anticancer activity among the flavonoids examined; or wogonin, even at low concentration, could have positive interaction with other phytochemicals; 2) while there is positive interaction among some flavonoids, some may antagonize each other; 3) the six flavonoids examined could not account for the antiproliferative activity of the extracts, strongly suggesting the participation of other flavonoids and/or non-flavonoid active phytochemicals. All the flavonoids dose-dependently inhibited proliferation of wogonin were the most potent with an IC 50 of approximately 100pM, while the IC 50 for other flavonoids varied from 125 to 250pM (0 Fig.2 ). This is in agreement with another study, where apigenin and wogonin showed better anti-proliferative activity than baicalein in human leukemia HL-60 cells [29] . It was apparent from the dose-response curves (0 Fig. 2 ) that the lowest concentration of a single flavonoid required to inhibit tumor cell proliferation to the 70% level of control value was 156pM apigenin (0 Fig.2A ) followed by 40pM chrysin (0 Fig. 2B ), which are equivalent to approximately 4.2 pg/mL of apigenin and 10.2 pg/mL of chrysin. This concentration was more than ten times higher than that detected in the active extracts required to achieve similar inhibition of proliferation {inhibition to 70% of control value was achieved with 125 pg/mL SinL extract (0 Fig. 1) , which contained only 0.26% apigenin (2.64pg/ mg, w/w) and 0.05% chrysin (0.54pg/mg, w/w) (0 Table 2 
)).
These data indicate potential additive/synergistic interactions among the flavonoids. A combination of the four flavonoids detected in SinL, namely, apigenin, baicalin, chrysin, and scutellarem, each 5pM, inhibited the proliferation of glioma cells by almost 50% (0 Fig. 2C) . However, individually, at 5pM, none showed any anti-proliferative activity. This result strongly suggested positive interaction among these flavonoids. The nature of the interaction, whether additive or synergistic, needs to be elucidated. In order to examine whether the antiproliferative activity is tumor-specific, two human malignant tumor cell lines (U87-MG glioma and MDA-MB-231 breast carcinoma) and the corresponding non-malignant cells (NHA, normal human astrocytes primary culture, and HMEC, non-malignant human mammary epithelial cell line) were cultured in the presence of selected Scutellaria extracts and isolated flavonoids for 96 h. Baicalein as well as SanL, SinL and SscL extracts significantly inhibited proliferation of the malignant glioma (U87-MG) cells (0 Fig. 3A) .
Similarly, all four Scute!Iaria extracts and six flavonoids significantly inhibited proliferation of breast cancer (MDA-MB-231) cells (0 Fig. 3C ). On the other hand, proliferation of non-malignant cells, NHA and HMEC, was not affected by any of the extracts or flavonoids tested (0 Figs. 3B and 313) . The antiproliferative activity of the extracts and individual flavonoids was comparable to that ofgenistein (0 Fig. 4) , a soy isoflavone known to have anti proliferative activity against breast cancers. The anti prol i ferative activity of selected Scutellaria extracts and flavonoids against another malignant glioma (U-251) and a prostate carcinoma (PC3) cell lines were also examined. Except for scutellarein, all flavonoids significantly inhibited the proliferation of both U-251 and PC3 cells at 100pM concentration (0 Figs. 3E and 3F ). Among the extracts, SanL and SocL, at 500 pg/mL, significantly inhibited the proliferation of U-251 cells (0 Fig. 3E) . Extracts of SanL, SinL and SocL significantly inhibited the proliferation of PC3 cells at 500 pg/mL, while inhibition by SscL was not significant (0 Fig. 3F ).
These results indicate that Scutellaria extracts or flavonoids target molecular mechanisms specific to the malignant phenotype.
In this context, we have observed inhibition of Akt/PKB and TGF- [18] . In our study, of the nine Scutellaria extracts that showed significant anti-proliferative activity, four extracts (SanL, SinL, SocL, and SscL) induced significantly high apoptosis in U87-MG glioma cells (0 Fig. 4A) . Incidentally, these four extracts were also those with relatively better antiproliferative activity compared to other extracts examined. Baicalein and baicalin displayed markedly higher induction of apoptosis compared to apigenin and wogonin (0 Fig. 4) , although apigenin and wogonin demonstrated better anti-proliferative activity than baicalein and baicalin (0 Fig. 1 ). This indicates a differential mechanism of anticancer activity among flavonoids, which in fact could also contribute to their positive interaction.
The differential antitumor mechanism of flavonoids was also reflected on their effect on cell cycle progression in gliomas. U87-MG cells, initially serum-starved for 12 h and then cultured in serum-containing medium for 72 h, had low number ofapoptotic cells (4%) and an even distribution of cells in G (33%) and G2
(24%) phases (0 Fig. 5A ). There was a significant enhancement in the number of cells in the G2 phase following treatment with apigenin (0 Fig. 513 ), baicalin (0 Fig. 5C ) and wogonin (0 Fig. 5G ).
A significant increase in the percentage of apoptotic cells (22%)
was observed following treatment with baicalein (0 Fig. 5C ). On the other hand, there was only marginal enhancement of cells in the G2 phase after treatment with chrysin (0 Fig. 5E ) and scutellarein(0 Fig. 5F ).
Our results are in agreement with some published studies, which have also shown enhancement of cells at G2/M phase after treatment with apigenin, baicalein, baicalin and wogonin [20] , [231. Another study has shown baicalein to induce dual GI /G2 arrest in rat heart endothelial cells [16] .
Various Scutellaria extracts also differed in their effect on cell i,i 1.14 ly, SocL extract exhibited marked enhancement of Cl population, whereas wogonin, the only flavonoid detected in this extract, enhanced G2/M population (0 Fig. 5 ). This further suggests an involvement of phytochemicals other than the six flavonoids that were examined. This study provided significant insight on how extracts from different tissues of various species of Scutellaria, grown tinder similar environmental conditions, could vary in flavonoid composition and antitumor activity. To the best of our knowledge, this is the first study comparing the six flavonoids in an array of anticancer activities, and demonstrating positive interaction among them. It is to be noted that, the content of phytochemicals in different parts of a plant varies, as affected by environmental factors 1301. In this study, Scutellaria plants were grown under the same greenhouse conditions; therefore, inferences drawn herein may not necessarily apply to similar plants growing in the wild. However, it may be concluded that under the uniform growth conditions maintained in this study, leaves of four species, namely, S. angulosa, S. integrifolia, S. ocmulgee and S. scandens would contain optimal phytochemical composition and could be sources of anticancer product(s) other than roots. This study allowed for the selection of these four species for further mechanistic and translational studies for adjuvant therapy of malignant tumors.
